TY  - RPRT
TI  - Molecular features influencing clinical outcome of advanced HER2-positive gastric cancer receiving trastuzumab plus chemotherapy.
AU  - Yu Lei
AU  - Danxi He
AU  - Jiqing Si
AU  - Junrong Yan
AU  - Minchi Yuan
PY  - 2025
DO  - 10.1080/07853890.2025.2581815
UR  - https://pubmed.ncbi.nlm.nih.gov/41195584/
ID  - 41195584
ER  -